Abstract
This study characterizes the exclusion of patients with chronic kidney disease (CKD) in randomized clinical trials of drug treatment for bladder, breast, colorectal, lung, and prostate cancer.
MeSH terms
-
Creatinine / blood
-
Humans
-
Neoplasms / complications
-
Neoplasms / drug therapy*
-
Patient Selection*
-
Randomized Controlled Trials as Topic*
-
Renal Insufficiency, Chronic / complications*